IL13 and allergic asthma: It was shown before by Bartemes et al. that PBMCs from allergic asthma patients produced significantly larger amounts of IL-5 and IL-13 after treatment with IL-25 or IL-33 than PBMCs from allergic rhinitis patients or healthy controls.